Beyond Air reports Q1 revenue $0.7M, net loss $0.27/share; receives Nasdaq bid-price deficiency notice

Beyond Air, Inc.

Revenue $0.7M, up 45% QoQ from $0.5M; net loss $12.2M ($0.27/share) vs $14.1M ($0.45) year ago.
Cash burn $13.1M; cash $21.4M; expects net cash burn <$30M in FY2025; breakeven target Q4 FY2026.
Nasdaq notice: bid price below $1.00 for 30 days; 180-day cure until Feb 4, 2025; may consider reverse split.
Amir Avniel appointed CEO of NeuroNOS (autism program); resigns as CBO and Board member effective Aug 15, 2024.
Revenue guidance >$10M for FY2025; commercial progress with LungFit PH in 55+ hospitals across 10 states.

item 2.02 item 3.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Amir Avniel

Director

XAIR · Beyond Air, Inc.

Effective: 2024-08-15
Filed: August 9, 2024, 7:59 PM ET

tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.

Departed

Amir Avniel

Chief Business Officer

XAIR · Beyond Air, Inc.

Effective: 2024-08-15
Filed: August 9, 2024, 7:59 PM ET

tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.

Appointed

Amir Avniel

Chief Executive Officer

XAIR · Beyond Air, Inc.

Effective: 2024-08-15
Filed: August 9, 2024, 7:59 PM ET

On August 6, 2024, Amir Avniel was appointed Chief Executive Officer of NeuroNOS Israel Limited overseeing the Company’s autism spectrum disorder program and tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Amir Avniel resigned as Director at Beyond Air, Inc..

Action: resigned
Role: Director

Exact text from the filing

tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Amir Avniel resigned as Chief Business Officer at Beyond Air, Inc..

Action: resigned
Role: Chief Business Officer

Exact text from the filing

tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Amir Avniel was appointed as Chief Executive Officer at Beyond Air, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On August 6, 2024, Amir Avniel was appointed Chief Executive Officer of NeuroNOS Israel Limited overseeing the Company’s autism spectrum disorder program and tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.

View on SEC.gov

Beyond Air, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-030972

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.